Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zelegent logo — Sleep Better. Live Better. Reduce the severity of snoring a...

Zelegent

Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effects.

Founded 2015 United States Newport Beach, United States 3 employees Series Unknown Total: $11.15M Health Care, Medical Devices

General Information

Company Name Zelegent
Founded Year 2015
Location United States Newport Beach, United States +1
Employees 3
Industries Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Zelegent moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Zelegent

Zelegent Inc. is a medical technology company founded in 2015, headquartered in United States, with the slogan "Sleep Better. Live Better." Zelegent focuses on reducing the severity of snoring, a common cause of short-term and long-term health issues. The company's flagship product is the Elevo® Snoring Intervention Set, which enables physicians to perform Elevoplasty® - a minimally invasive, physician’s office-based procedure designed to treat patients with mild to moderate snoring. The S.I.LE.N.C.E. Clinical Study, submitted to the FDA to achieve FDA Clearance, demonstrated that 3 out of 4 patients experienced a reduction in snoring at 30 days post-procedure and significant improvement in sleep quality and daytime alertness. This study is available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042659/. With a $8.65M Venture Round investment received on 09 October 2020, Zelegent is making strides in the Health Care industry, addressing an issue that affects approximately 45% of people who snore at least sometimes and 25% who snore regularly at volumes high enough to disturb sleeping partners. The negative impact of snoring on health, including the risk of Obstructive Sleep Apnea, heart conditions, and other serious health issues, highlights the significance of Zelegent's mission. Zelegent's innovation not only targets the health of individuals who snore but also aims to improve the sleep quality and well-being of their partners. With a focus on addressing both short-term and long-term health effects, Zelegent has the potential to make a substantial difference in the lives of many.

Taxonomy: Sleep Technology, Snoring Treatment, Minimally Invasive Procedure, Health Innovation, Sleep Quality Improvement, Sleep Disorders, ENT Health, Obstructive Sleep Apnea, Sleep Health, Clinical Studies, Sleep Medicine, Patient Wellness, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 09 Oct 2020
Seed Round •••••• - 19 Nov 2015
Non Equity Assistance •••••• 1
Investor
08 May 2015

FAQ About Zelegent

Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effects.
Zelegent was founded in 2015.
Zelegent is headquartered in Newport Beach, United States.
Zelegent operates in the following industries: Health Care, Medical Devices.
Zelegent has approximately 3 employees.
Zelegent has completed 3 funding rounds, raising a total of $11.15M. The latest funding stage is Series Unknown.

We're actively collecting intelligence on Zelegent.

Track Zelegent to get notified

Don't just browse. Track.

Signal Tracker monitors Zelegent and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes